Embed Size (px)
Citation preview
The MOBI4Health project has received funding from 7th Framework ProgrammeThe MOBI4Health project has received funding from 7th Framework Programme of the European Commission under Grant Agreement No. 316094.
The Intercollegiate Faculty of Biotechnology University of Gdansk and Medical University of Gdansk (IFB UG & MUG) has been created in 1993 in response to a rising challenge from modern biotechnology. It combines two universities in the effort to achieve one goal: the highest quality research and education in the area of biotechnology. The scientists at IFB UG & MUG have an origin in different disciplines: biology, medicine, pharmacy and chemistry. They have been teaching students and conducting high-quality research work thanks to numerous grants from national and international funding bodies. Currently, the structure of the IFB UG & MUG consists of 17 research teams, each gathered around a specialized discipline. Skilled doctoral students complete the research potential of the Faculty.
UNIVERSITY OF GDANSK
Centre of Molecular Biotechnology for Healthy Life
Biotech solutions bringing healthto living organisms and environment
supported bymass spec-focused research platform
Project Coordinator: Prof. Krzysztof BielawskiIntercollegiate Faculty of Biotechnology UG & MUG Address: Kladki 24, 80-822 Gdansk, PolandTel.: +48 58 523 63 14 E-mail: [email protected]
Project acronym: MOBI4HealthProgramme acronym: FP7-REGPOTProject duration: 36 (+6) monthsBudget: EUR 5 214 534EC contribution: EUR 4 667 006http://www.mobi4health.ug.edu.pl
Molecular Tools for Healthy LifeAc
tion
plan MOBI4Health Centre will contribute to improved research capacity through:
HUMAN & ENVIRONMENT
HUUMANENVIRONM
ENT
🗺 Plant pathogensidentifications & pathogenicity factors characterization
🗺 Biomarkers of liver diseases
🗺 Environmental friendly production of lipids for industry
🗺 Cancerogens, drugs, UVA/UVB 🗺 Bacterial
sporesas vaccine vehicles
🗺 Biomarkers of mitochondrial diseases
🗺 Tools for biocontrol of plant pathogens
🗺 Extrachromosomal genetics elements
🗺 Recombinant antiviral vaccines
🗺 Plant secondary metabolitesas pharmaceuticals
🗺 Impact of environment on proteins activity
🗺 Chaperons inhealth control
🗺 Modulation of biological activity of ligands
🗺 Modeling of receptor-ligand interactions
🗺 Study of mechanismsof viral cell-to-cell spread
🗺 Human amyloidogenic proteins
🗺 Study of novelcompounds with potential pharmaceutical application
ENVI
ROM
ENTA
L IN
NOVA
TION
S
PHARMACEUTICAL INNOVATIONS DIAGNOSTICS INNOVATIONS
🗺 Human cancer biomarkers
�🗺 Employment of new experienced researchers and specialists for the mass spec core facility to strenghten the research potential;
�🗺 Acquisition of complex mass spec equipment to ensure high--class analysis of proteins and nucleic acids;
�🗺 Intensification of international cooperation with leading European partners;
�🗺 Dissemination of skills in form of hands-on courses, workshops and international conferences;
�🗺 Implementation of an IPR & Innovation Strategy to commercialize results and ensuring IPR protection.
Increasing Human Potential
Twinning
Equipment
Innovation Capacity Building
Conferences and Workshops
Visibility
Management
External Evaluation
Objectives of the project
MOBI4Health projectwill support the Intercollegiate
Faculty of BiotechnologyUniversity of Gdansk and Medical
University of Gdansk (IFB UG & MUG) in complex activities to boost its research
and innovation potential through establishing a Centre of Molecular
Biotechnology for Healthy Life: MOBI4Health Centre.
University of Nottingham, UK
ENSAIA-INPL, FR
Philipps-Universitaet Marburg, DE
INSA Lyon, FR
University of Konstanz, DE
Centro de Investigaciones Biologicas, Madrid, ES
Federico II University of Naples, IT
University of Göttingen, DE
INSERM U846 – Stem-Cell and Brain Research Institute, FR
The Biomedical Research Institute FORTH, Ioaninna, GR
MOBI4Health Networking European partners
